...
首页> 外文期刊>Molecular cancer research: MCR >Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients
【24h】

Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients

机译:表述调节染色体14q32 miRNA簇诱导转移并预测肺腺癌患者的预后差

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Most lung cancer deaths are related to metastases, which indicates the necessity of detecting and inhibiting tumor cell dissemination. Here, we aimed to identify miRNAs involved in metastasis of lung adenocarcinoma as prognostic biomarkers and therapeutic targets. To that end, lymph node metastasis–associated miRNAs were identified in The Cancer Genome Atlas lung adenocarcinoma patient cohort (sequencing data; n = 449) and subsequently validated by qRT-PCR in an independent clinical cohort ( n = 108). Overexpression of miRNAs located on chromosome 14q32 was associated with metastasis in lung adenocarcinoma patients. Importantly, Kaplan–Meier analysis and log-rank test revealed that higher expression levels of individual 14q32 miRNAs (mir-539, mir-323b, and mir-487a) associated with worse disease-free survival of never-smoker patients. Epigenetic analysis including DNA methylation microarray data and bisulfite sequencing validation demonstrated that the induction of 14q32 cluster correlated with genomic hypomethylation of the 14q32 locus. CRISPR activation technology, applied for the first time to functionally study the increase of clustered miRNA levels in a coordinated manner, showed that simultaneous overexpression of 14q32 miRNAs promoted tumor cell migratory and invasive properties. Analysis of individual miRNAs by mimic transfection further illustrated that miR-323b-3p, miR-487a-3p, and miR-539-5p significantly contributed to the invasive phenotype through the indirect regulation of different target genes. In conclusion, overexpression of 14q32 miRNAs, associated with the respective genomic hypomethylation, promotes metastasis and correlates with poor patient prognosis in lung adenocarcinoma. Implications: This study points to chromosome 14q32 miRNAs as promising targets to inhibit tumor cell dissemination and to predict patient prognosis in lung adenocarcinoma. Mol Cancer Res; 16(3); 390–402. ?2018 AACR .
机译:大多数肺癌死亡与转移有关,表明检测和抑制肿瘤细胞播种的必要性。在这里,我们的旨在鉴定患有肺腺癌转移的miRNA作为预后生物标志物和治疗靶标。为此,在癌症基因组地图集腺癌患者队列中鉴定了淋巴结转移相关的miRNA(测序数据; n = 449),随后在独立的临床队列中通过QRT-PCR验证(n = 108)。位于染色体14Q32上的miRNA的过度表达与肺腺癌患者转移相关。重要的是,Kaplan-Meier分析和对数秩检验显示,与NOVE-SPOUS患者的无病生存率更差的单个14Q32 miRNA(miR-539,miR-323b和miR-487a)的表达水平更高。表观遗传分析包括DNA甲基化微阵列数据和亚硫酸氢盐测序验证表明,14Q32簇的诱导与14Q32基因座的基因组甲基化相关。 CrispRP激活技术首次应用于在功能上以协调的方式研究聚类miRNA水平的增加,表明同时过表达14Q32 miRNA促进肿瘤细胞迁移和侵入性。通过模拟转染对单个miRNA的分析进一步说明了MiR-323b-3p,miR-487a-3p和miR-539-5p通过间接调节不同靶基因的间接调节显着导致侵入性表型。总之,与各自的基因组黄甲基化相关的14Q32 miRNA的过度表达促进转移和与肺腺癌中患者患者预后的差异相关。含义:本研究指出染色体14 Q32 miRNA作为抑制肿瘤细胞传播的有前途的靶点,并预测肺腺癌中的患者预后。 Mol Cancer Res; 16(3); 390-402。 ?2018年AACR。

著录项

  • 来源
    《Molecular cancer research: MCR》 |2018年第3期|共13页
  • 作者单位

    Institute of Pathology University Hospital Heidelberg Heidelberg Germany.;

    Division of Epigenetics DKFZ-ZMBH Alliance German Cancer Research Center Heidelberg Germany.;

    Center for Modeling and Simulation in the Biosciences (BIOMS) University of Heidelberg Heidelberg;

    Medical Research Centre University of Heidelberg Mannheim Germany.;

    Center for Modeling and Simulation in the Biosciences (BIOMS) University of Heidelberg Heidelberg;

    Division of Epigenetics DKFZ-ZMBH Alliance German Cancer Research Center Heidelberg Germany.;

    Institute of Computational Biology Helmholtz Center Munich German Research Center for;

    Institute of Computational Biology Helmholtz Center Munich German Research Center for;

    Department of Cancer Biology &

    Genetics Memorial Sloan Kettering Cancer Center New York New York.;

    Institute of Medical Biometry and Informatics University of Heidelberg Heidelberg Germany.;

    Institute of Pathology University Hospital Heidelberg Heidelberg Germany.;

    Medical Research Centre University of Heidelberg Mannheim Germany.;

    Institute of Pathology University Hospital Heidelberg Heidelberg Germany.;

    Institute of Computational Biology Helmholtz Center Munich German Research Center for;

    Institute of Computational Biology Helmholtz Center Munich German Research Center for;

    Medical Research Centre University of Heidelberg Mannheim Germany.;

    Translational Lung Research Center Heidelberg (TLRC‐H) member of the German Center for Lung;

    Translational Lung Research Center Heidelberg (TLRC‐H) member of the German Center for Lung;

    Institute of Pathology University Hospital Heidelberg Heidelberg Germany.;

    Institute of Pathology University Hospital Heidelberg Heidelberg Germany.;

    Center for Modeling and Simulation in the Biosciences (BIOMS) University of Heidelberg Heidelberg;

    Institute of Pathology University Hospital Heidelberg Heidelberg Germany.;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号